{"id":"NCT00489541","sponsor":"Boston Scientific Corporation","briefTitle":"TAXUS PERSEUS Small Vessel","officialTitle":"A Prospective Evaluation in a Non-Randomized Trial of the Safety and Efficacy of the Use of the TAXUS® ElementTM Paclitaxel-Eluting Coronary Stent System for the Treatment of De Novo Coronary Artery Lesions in Small Vessels","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-07","primaryCompletion":"2009-06","completion":"2013-10","firstPosted":"2007-06-21","resultsPosted":"2011-06-28","lastUpdate":"2014-05-08"},"enrollment":224,"design":{"allocation":"NON_RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Coronary Artery Disease"],"interventions":[{"type":"DEVICE","name":"Percutaneous Coronary Intervention (PCI) with paclitaxel-eluting stent (TAXUS Element) implantation","otherNames":[]}],"arms":[{"label":"TAXUS Element Stent System","type":"EXPERIMENTAL"}],"summary":"The purpose of the TAXUS PERSEUS Small Vessel trial is to evaluate the safety and efficacy of the next-generation Boston Scientific TAXUS paclitaxel-eluting coronary stent system (TAXUS® ElementTM) for the treatment of de novo atherosclerotic lesions of up to 20 mm in length in native coronary arteries of ≥ 2.25 mm to \\< 2.75 mm diameter.","primaryOutcome":{"measure":"In-stent Late Loss Measured by Quantitative Coronary Angiography (QCA)","timeFrame":"9 months post-index procedure","effectByArm":[{"arm":"TAXUS Element","deltaMin":0.38,"sd":0.51},{"arm":"Historical Control Bare Metal Stent (BMS)","deltaMin":0.8,"sd":0.53}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":28},"locations":{"siteCount":28,"countries":["United States"]},"refs":{"pmids":["20059766"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":100,"n":224},"commonTop":["Angina pectoris","Non-cardiac chest pain","Nausea","Fatigue","Dyspnoea"]}}